Pulmonary Fibrosis After COVID-19: Treatments and Transplant

Hear from pulmonologists about the outlook of post-COVID chronic lung disease, including a discussion of what we understand about the factors that contribute to the development of post-COVID fibrosis, the role of emerging therapies such as antifibrotics and antiinflammatory agents, and when to consider lung transplantation. (Originally recorded October 28, 2021) Moderator: Holly Keyt, MD, FCCP. Panelists: Anna Podolanczuk, MD, MS; Corey Kershaw, MD, FCCP; and Harpreet Grewal, MD. For more tools to help in the fight against COVID-19, visit CHEST’s COVID-19 Resource Center at chestnet.org/COVID19.